In the bitter cold of the “four-nines” winter, the biting wind could not dampen the enthusiasm across Cangzhou City for the digital transformation of its manufacturing sector. On January 17, a field observation delegation led by top government officials from Cangzhou, comprising representatives from relevant government departments and heads of manufacturing enterprises, made its inaugural stop at Hebei Guangxiang Pharmaceutical Co., Ltd., part of Shijiazhuang Sihua Pharmaceutical Group, to witness firsthand the vibrant momentum that digital transformation has brought to the company.

In the central control room of Guangxiang Pharmaceutical, members of the observation delegation paused before the massive DCS (Distributed Control System) display, where streams of data pulsed like a heartbeat, silently linking every production stage in the plant. The ever-changing curves and charts vividly depicted every detail of the manufacturing process in real time. Zhang Zanyuan, General Manager of Guangxiang Pharmaceutical, pointed to the large screen and explained: “This is the digital and intelligent fully automated management platform we have built for active pharmaceutical ingredients. By deeply integrating process control, data acquisition, and the automation control system, we have achieved systematic and integrated process management.”

If the central control room is the brain, then each production workshop is an intelligent body that executes precise operations in response to commands, vividly exemplifying a “one-click” smart manufacturing model. Zhang Zanyuan explained: “Relying on the intelligent DCS system, equipment processes massive amounts of data in real time, rapidly extracts key information, and thereby achieves intelligent resource management and refined operational control.”

During the on-site presentation, the most striking detail was the contrast between past and present: in the past, a single production line often relied on multiple “seasoned” workers who had to make frequent, experience-based adjustments; today, from raw-material feeding to finished-product discharge, most stages are handled by automated, digital processes—precise and highly efficient.

In addition, the digital platform for production safety integrates key safety elements—such as the “dual-control” mechanism of risk-based classification and control combined with hazard identification and remediation, as well as predictive equipment maintenance—into a unified digital network. This means that every alert is no longer dependent on human eyes or judgment; instead, the system makes proactive decisions based on real-time data—precisely the most vivid illustration of the intelligent transformation of production safety.

Among the observers, people frequently raised their smartphones to capture the fleeting moments when the charts dynamically shifted and evolved. As industrial operations were translated into the most intuitive language of numbers, a quiet vision of the industry’s transformation toward the future began to take shape in the hearts of every attendee.

“Our production efficiency has increased by more than 40%, and both production and management costs have been significantly reduced, providing strong impetus for the company’s transformation toward intelligent, green, and integrated operations. Today, our flagship product—caffeine—is exported to over 60 countries and regions worldwide.” This remarkable achievement has drawn widespread praise from the many business representatives in attendance. When green processes are deeply integrated with digital control systems, the benefits extend far beyond enhanced capacity and efficiency: Guangxiang Pharmaceutical has obtained Cangzhou City’s first Carbon Footprint Certification, the European Pharmacopoeia Compliance Certificate (CEP) for caffeine, and the Authorized Economic Operator (AEO) certification from customs—each of these not only underscores the company’s commitment to social responsibility but also serves as a crucial “entry ticket” to international markets.

Meanwhile, being recognized as a National Green Factory, an Advanced-Level Smart Factory in Hebei Province, and a Benchmark Demonstration Enterprise for the Industrial Internet in Hebei Province—these accolades are more than mere labels; they are powerful evidence of the tangible results Guangxiang Pharmaceutical has achieved in accelerating its digital transformation. As one visiting entrepreneur remarked: “What we see here goes beyond just smart systems and equipment—it’s a comprehensive transformation framework that spans R&D, production, management, safety, and logistics. This kind of exploration and practical implementation holds significant reference value for us.”

Where should we begin, and how can we align our efforts with our specific circumstances to advance the high-quality, high-end development of manufacturing? This “overview-and-guidance”-style observation event has long since transcended the superficial “highlight showcase” of benchmark enterprises. By drawing on cutting-edge ideas and core pathways for the deep integration of digital technologies with the real economy, it aims to stimulate the endogenous driving forces behind high-quality manufacturing development and catalyze a profound transformation in both development philosophy and practical models.

The experience of Guangxiang Pharmaceutical demonstrates that high-quality, high-end development in the manufacturing sector must be driven by digitalization, embedding technological applications as systemic capabilities across the enterprise and thereby enabling a comprehensive reconfiguration of its development model. This, perhaps, is the most fundamental demonstration value of the “Guangxiang Approach.” Zhang Zanyuan, General Manager of Guangxiang Pharmaceutical, stated that while deepening R&D in high-end active pharmaceutical ingredients, the company is actively advancing the intelligent transformation of its entire industrial chain, leveraging this initiative to foster collaborative transformation among upstream and downstream partners.

Through the interplay of light and shadow reflected on the central control room’s screens, what people see is not only the present state of a benchmark enterprise, but also the courage and imagination required for an entire city—and an entire industry—to embrace change, strive for excellence, and welcome the arrival of spring. Guangxiang Pharmaceutical’s pioneering efforts are like the very first “spring shoots” breaking through frozen soil; each such transformative endeavor is reshaping and redefining the new logic for future industrial innovation, iteration, and transformation and upgrading. It is easy to foresee that, guided by these “spring shoots,” more and more blossoms of transformation will emerge, collectively painting a vibrant springtime panorama of intelligent manufacturing.